N-(二环丙基甲基)-4,5-二氢噁唑-2-胺

N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine

产品编号.: A187041 CAS号: 54187-04-1
分子式: C10H16N2O 分子量: 180.24684
纯度: 98% MDL NO.:

中文名称:N-(二环丙基甲基)-4,5-二氢噁唑-2-胺
CAS号:54187-04-1
中文别名:利美尼啶;N-(双环丙基甲基)-4,5-二氢-2-噁唑胺;利美尼定;瑞曼尼定
英文名称:N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine
英文别名:Rilmenidine;N-(Dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine;Oxaminozoline;N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine;Rilmenidine hemifumarate salt;EINECS 259-021-0;Hyperium;S 3341;HY-100490;NCGC00015884-02;EU-0101104;SY267932;CHEBI:8862;P67IM25ID8;N-(dicyclopropylmethyl)-4,5-dihydrooxazol-3-ium-2-amine;Tox21_110254;NCGC00015884-05;DB11738;Rilmenidia [Spanish];DTXCID1025194;ARSENICTRIFLUORIDE;AB00513728-09;A830020;Tox21_110254_1;NSC664312;HMS2089G15;NCGC00015884-06;CAS-54187-04-1;BDBM50070328;NCGC00015884-01;SDCCGSBI-0051073.P002;CQXADFVORZEARL-UHFFFAOYSA-N;NCGC00015884-08;CHEMBL289480;FT-0630668;NS00017270;NSC-664312;SCHEMBL114420;NCGC00015884-07;EN300-8092697;BPBio1_001149;HMS3263M10;NCGC00015884-10;(N-dicyclopropylmethyl)-amino-2-oxazoline;N-(Dicyclopropylmethyl)-N-(4,5-dihydro-1,3-oxazol-2-yl)amine;2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-;Hyperium (TN);NCGC00015884-11;NCGC00015884-04;Oxazolidine, 2-((dicyclopropylmethyl)imino)-;Prestwick2_000982;NCGC00015884-03;54187-04-1;LP01104;MFCD00865924;AB00514648;Rilmenidine [INN];Tox21_501104;D08482;NCGC00015884-09;SR-01000002992-3;NCGC00015884-13;W-105661;R-134;Q967973;SR-01000002992-4;AKOS006273431;NCGC00021689-05;NCGC00021689-02;Lopac-R-134;RILMENIDINE [MI];NSC 664312; Oxaminozoline; Rilmenidene;S 3341;UNII-P67IM25ID8;2-Oxazolamine, 4,5-dihydro-N-(dicyclopropylmethyl)-;SPBio_002944;Prestwick0_000982;N-(Dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine;;N-(Dicyclopropylmethyl)-4,5-dihydrooxazol-2-amine;Lopac0_001104;CS-0019423;SR-01000002992;Prestwick3_000982;L001230;NCGC00015884-19;AB07513;Rilmenidine (INN);2-(dicyclopropylmethylamino) oxazoline;NCGC00021689-04;Prestwick1_000982;Methylamine, 1,1-dicyclopropyl-N-(2-oxazolinyl)-;Rilmenidinum [Latin];BSPBio_001043;Tocris-0790;RILMENIDINE [WHO-DD];CCG-205180;NCI60_022181;DTXSID3045194;BRN 1211287;NCGC00261789-01;N-(Dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine;NCGC00021689-06;DB-052512;G78307;Rilmenidinum (Latin);Rilmenidia;S-3341-3;2-((Dicyclopropylmethyl)imino)oxazolidine;rilmenidina;Albarel;GTPL13356;BRD-K01638814-051-16-8;BRD-K01638814-011-01-4;Rilmenidinum;C02AC06;S-3341;2-(Dicyclopropylmethylamino)-2-oxazoline
EINEC:259-021-0
分子式:C10H16N2O
分子量:180.24684
搜索质检报告(COA)
搜索MSDS
已经到最底了
批量搜索 关闭
批处理可以通过CAS号,CAS号,每行一个搜索
...

N-(二环丙基甲基)-4,5-二氢噁唑-2-胺
Rilmenidine;N-(Dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine;Oxaminozoline;N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine;Rilmenidine hemifumarate salt;EINECS 259-021-0;Hyperium;S 3341;HY-100490;NCGC00015884-02;EU-0101104;SY267932;CHEBI:8862;P67IM25ID8;N-(dicyclopropylmethyl)-4,5-dihydrooxazol-3-ium-2-amine;Tox21_110254;NCGC00015884-05;DB11738;Rilmenidia [Spanish];DTXCID1025194;ARSENICTRIFLUORIDE;AB00513728-09;A830020;Tox21_110254_1;NSC664312;HMS2089G15;NCGC00015884-06;CAS-54187-04-1;BDBM50070328;NCGC00015884-01;SDCCGSBI-0051073.P002;CQXADFVORZEARL-UHFFFAOYSA-N;NCGC00015884-08;CHEMBL289480;FT-0630668;NS00017270;NSC-664312;SCHEMBL114420;NCGC00015884-07;EN300-8092697;BPBio1_001149;HMS3263M10;NCGC00015884-10;(N-dicyclopropylmethyl)-amino-2-oxazoline;N-(Dicyclopropylmethyl)-N-(4,5-dihydro-1,3-oxazol-2-yl)amine;2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-;Hyperium (TN);NCGC00015884-11;NCGC00015884-04;Oxazolidine, 2-((dicyclopropylmethyl)imino)-;Prestwick2_000982;NCGC00015884-03;54187-04-1;LP01104;MFCD00865924;AB00514648;Rilmenidine [INN];Tox21_501104;D08482;NCGC00015884-09;SR-01000002992-3;NCGC00015884-13;W-105661;R-134;Q967973;SR-01000002992-4;AKOS006273431;NCGC00021689-05;NCGC00021689-02;Lopac-R-134;RILMENIDINE [MI];NSC 664312; Oxaminozoline; Rilmenidene;S 3341;UNII-P67IM25ID8;2-Oxazolamine, 4,5-dihydro-N-(dicyclopropylmethyl)-;SPBio_002944;Prestwick0_000982;N-(Dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine;;N-(Dicyclopropylmethyl)-4,5-dihydrooxazol-2-amine;Lopac0_001104;CS-0019423;SR-01000002992;Prestwick3_000982;L001230;NCGC00015884-19;AB07513;Rilmenidine (INN);2-(dicyclopropylmethylamino) oxazoline;NCGC00021689-04;Prestwick1_000982;Methylamine, 1,1-dicyclopropyl-N-(2-oxazolinyl)-;Rilmenidinum [Latin];BSPBio_001043;Tocris-0790;RILMENIDINE [WHO-DD];CCG-205180;NCI60_022181;DTXSID3045194;BRN 1211287;NCGC00261789-01;N-(Dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine;NCGC00021689-06;DB-052512;G78307;Rilmenidinum (Latin);Rilmenidia;S-3341-3;2-((Dicyclopropylmethyl)imino)oxazolidine;rilmenidina;Albarel;GTPL13356;BRD-K01638814-051-16-8;BRD-K01638814-011-01-4;Rilmenidinum;C02AC06;S-3341;2-(Dicyclopropylmethylamino)-2-oxazoline